| __timestamp | Dr. Reddy's Laboratories Limited | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 22746000000 |
| Thursday, January 1, 2015 | 62786000000 | 21536000000 |
| Friday, January 1, 2016 | 62427000000 | 21685000000 |
| Sunday, January 1, 2017 | 62453000000 | 25354000000 |
| Monday, January 1, 2018 | 65724000000 | 27091000000 |
| Tuesday, January 1, 2019 | 70421000000 | 27556000000 |
| Wednesday, January 1, 2020 | 80591000000 | 28427000000 |
| Friday, January 1, 2021 | 86645000000 | 23402000000 |
| Saturday, January 1, 2022 | 100551000000 | 24596000000 |
| Sunday, January 1, 2023 | 42907000000 | 26553000000 |
| Monday, January 1, 2024 | 115557000000 | 27471000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Johnson & Johnson, a stalwart in healthcare, and Dr. Reddy's Laboratories, a leading Indian multinational, offer a fascinating comparison. From 2014 to 2023, Dr. Reddy's Laboratories consistently reported higher costs of revenue, peaking in 2024 with a staggering 115% increase from 2014. In contrast, Johnson & Johnson's costs remained relatively stable, with a modest 17% rise over the same period.
Dr. Reddy's Laboratories' cost of revenue surged by over 78% from 2014 to 2022, reflecting its aggressive expansion and market penetration strategies. Meanwhile, Johnson & Johnson's costs showed a steady trend, highlighting its focus on efficiency and innovation. Notably, 2023 data for Dr. Reddy's is missing, indicating potential reporting delays or strategic shifts. This comparison underscores the diverse strategies of these pharmaceutical giants in navigating global markets.
Cost of Revenue Comparison: Johnson & Johnson vs Regeneron Pharmaceuticals, Inc.
Johnson & Johnson vs Viatris Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Johnson & Johnson and Cytokinetics, Incorporated's Expenses
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: AbbVie Inc. vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Intra-Cellular Therapies, Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Exelixis, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Amneal Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Perrigo Company plc
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and MiMedx Group, Inc.